Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Verinurad in Renal Impairment
NCT02219516Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Aug 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of verinurad in gout (4 arms), sponsored by Ardea Biosciences, Inc. Primary endpoints: Maximum Observed Plasma Concentration, Time of Occurrence of Maximum Observed Concentration and 6 more. Started Aug 2014; status: completed.
02
Drugs
verinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT02219516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219516.